SHAPE to Conduct Task Force Conference
on the Latest Heart Attack and Stroke Prevention Science

The Society for Heart Attack Prevention & Eradication (SHAPE) announces its upcoming meeting on
Cardiovascular Risk Assessment in the Asymptomatic Population to be held on Friday, May 10, 2013.

Houston, April 29, 2013 :-The latest in its ongoing series of scientific conferences on preventive cardiology through public awareness and early detection of atherosclerosis, the meeting includes presentations by some of the most distinguished researchers, clinicians and academicians in the field.

Those presenting include Morteza Naghavi, MD, PK Shah, MD, Matthew Budoff, MD, Tasneem Naqvi, MD, J. David Spence, MD and Harvey Hecht, MD.

For more information on the SHAPE Guidelines for cardiovascular prevention and its past conferences go to

SHAPE II Task Force Conference

Updates on Cardiovascular Risk Assessment in the Asymptomatic Population Friday, May 10, 2013 at 3:00 PM (U.S. Central Daylight Savings Time)Chaired by:Morteza Naghavi, M.D. and PK Shah, M.D.


Morteza Naghavi, M.D.


Morteza Naghavi, M.D., Founder of SHAPE and Executive Chairman of the SHAPE Task Force.

PK Shah, M.D.

3:05 PM

Upcoming NCEP IV and what it needs to address.
(5 to 10 minute presentation + discussion)
PK Shah, M.D., Director, Division of Cardiology; Director, Oppenheimer Atherosclerosis Research Center; Shapell and Webb Family Chair in Clinical Cardiology; Professor, Cedars-Sinai Professorial Series

Matthew J. Budoff, M.D.,

3:20P PM

New data on noninvasive imaging of atherosclerosis using coronary calcium
(5 to 10 minute talk + discussion)
Matthew J. Budoff, M.D., Professor of Medicine, David Geffen School of Medicine at UCLA; Director of Cardiac CTA at Los Angeles Biomedical Research Center, Harbor-UCLA Medical Center

Tasneem Naqvi, M.D.

3:35 PM

New data on noninvasive imaging of atherosclerosis using CIMT
(5 to 10minute talk + discussion)

Tasneem Naqvi, M.D., Professor of Clinical Medicine; Director, Echocardiography Services; Medical Director, Non Invasive Diagnostic Services, USC Cardiac and Vascular Institute, Keck School of Medicine USC

J. David Spence, M.D.

3:50 PM

3D carotid imaging & measurement of plaque volume and total plaque area
(5 to 10 minute talk + discussion)

J. David Spence, M.D., Professor of Neurology & Clinical Pharmacology, Western University; Director, Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Inst, London, Ontario, CA

Harvey S. Hecht, M.D

4:05 PM

Repeated coronary calcium scanning (1-5 year follow up)
(5 to 10 minute talk + discussion)

Harvey S. Hecht, M.D. , Director of Cardiovascular Computed Tomography
Lenox Hill Heart & Vascular Institute

Moderated Discussions

  • When will be the right time to issue SHAPE II, and how NCEP 4 will affect it?
  • Barriers to the adoption of SHAPE and noninvasive imaging for primary prevention –reimbursement and what else?
  • Physician education and SHAPE certification, what have we done and what are we missing?
  • Progress to obtain reimbursement for CAC and CIMT with insurance companies and Medicare/Medicaid

Invited Faculty

Arthur Agatston, M.D., John J. Badimon, Ph.D., Daniel Berman, M.D., Roger Blumenthal, M.D., Matthew Budoff, M.D., Jay N. Cohn, M.D., Michael Davidson, M.D., James E. Ehrlich, M.D., Raimund Erbel, M.D., Erling Falk, M.D., Ph.D., Zahi A. Fayad, Ph.D., Sergio Fazio, M.D., Ph.D., Steve Feinstein, M.D., Jeffrey Fine, Ph.D., Valentin Fuster, M.D., Ph.D., Craig J. Hartley, Ph.D., Harvey S. Hecht, M.D., Howard Hodis, M.D., Ioannis A. Kakadiaris, Ph.D., Sanjay Kaul, M.D., Iftikhar J. Kullo, M.D., Daniel M. Lane, M.D., Ph.D., Roxana Mehran, M.D., Morteza Naghavi, M.D., Tasneem Naqvi, M.D., Jagat Narula, M.D., Khurram Nasir, M.D., Paolo Raggi, M.D., John A. Rumberger, Ph.D., M.D., George P. Rodgers, M.D., James HF Rudd Ph.D., Robert S. Schwartz, M.D., PK Shah, M.D., Leslee J Shaw, Ph.D., Henrik Sillesen, MD, D.MSc., J. David Spence, M.D., H. Robert Superko, M.D., Allen Taylor, M.D., PJ Touboul, M.D.


The Society for Heart Attack Prevention and Eradication (SHAPE) is a tax-exempt organization founded by Dr. Morteza Naghavi, former faculty member of the Texas Heart Institute and the University of Texas in Houston. SHAPE promotes education and research related to early detection, prevention and treatment of arterial plaque, the underlying cause of heart attacks. SHAPE is committed to raising public awareness about noninvasive, cost effective screening programs that detect potential heart problems in asymptomatic populations. Additional information is available at  For more information about how to get involved with SHAPE and become a volunteer, please email us at: or call 713-529-4484.